Goldberg Daniel R, Hao Ming-Hong, Qian Kevin C, Swinamer Alan D, Gao Donghong A, Xiong Zhaoming, Sarko Chris, Berry Angela, Lord John, Magolda Ronald L, Fadra Tazmeen, Kroe Rachel R, Kukulka Alison, Madwed Jeffrey B, Martin Leslie, Pargellis Christopher, Skow Donna, Song Jinhua J, Tan Zhulin, Torcellini Carol A, Zimmitti Clare S, Yee Nathan K, Moss Neil
Department of Medicinal Chemistry, Boehringer Ingelheim Pharmaceuticals, Inc., Research and Development Center, Ridgefield, Connecticut 06877, USA.
J Med Chem. 2007 Aug 23;50(17):4016-26. doi: 10.1021/jm070415w. Epub 2007 Jul 20.
Integration of computational methods, X-ray crystallography, and structure-activity relationships will be disclosed, which lead to a new class of p38 inhibitors that bind to p38 MAP kinase in a Phe out conformation.
将揭示计算方法、X射线晶体学和构效关系的整合,这会产生一类新的p38抑制剂,它们以苯丙氨酸向外构象与p38丝裂原活化蛋白激酶结合。